---
title: "Cefditoren Pivoxil - Staphylococcal Infections"
sidebar: mydoc_sidebar
permalink: db01066-mesh-d013203-1.html
toc: false 
---


Path ID: `DB01066_MESH_D013203_1`
{% include image.html url="images/db01066-mesh-d013203-1.png" file="db01066-mesh-d013203-1.png" alt="db01066-mesh-d013203-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C057710 | Cefditoren pivoxil | Drug |
| MESH:C073460 | Cefditoren | ChemicalSubstance |
| InterPro:IPR001460 | Penicillin-binding proteins | GeneFamily |
| GO:0019835 | Cytolysis | BiologicalProcess |
| MESH:D010457 | Peptidoglycan | ChemicalSubstance |
| GO:0009273 | Peptidoglycan-based cell wall biogenesis | BiologicalProcess |
| NCBITaxon:1280 | Staphylococcus aureus | OrganismTaxon |
| MESH:D013203 | Staphylococcal infections | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cefditoren Pivoxil | HAS METABOLITE | Cefditoren |
| Cefditoren | DECREASES ACTIVITY OF | Penicillin-Binding Proteins |
| Penicillin-Binding Proteins | DECREASES SYNTHESIS OF | Peptidoglycan |
| Peptidoglycan | DISRUPTS | Peptidoglycan-Based Cell Wall Biogenesis |
| Peptidoglycan | INCREASES ACTIVITY OF | Cytolysis |
| Cytolysis | IN TAXON | Staphylococcus Aureus |
| Peptidoglycan-Based Cell Wall Biogenesis | IN TAXON | Staphylococcus Aureus |
| Staphylococcus Aureus | CAUSES | Staphylococcal Infections |
|---------|-----------|---------|

Comment: Cefditoren pivoxil is the pivaloyloxymethyl ester prodrug of cefditoren

Reference: 
  - [https://go.drugbank.com/drugs/DB01066](https://go.drugbank.com/drugs/DB01066)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Cefditoren-pivoxil#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Cefditoren-pivoxil#section=Pharmacology-and-Biochemistry)
